Skye Bioscience, Inc. — Director's Dealing 2015

Jan 13, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nemus Bioscience, Inc. (NMUS)
CIK: 0001516551
Period of Report: 2015-01-09

Reporting Person: GEORGE THOMAS (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-01-09	Stock Option (Right to Buy)	$3.00	A	40000	Acquired	2025-01-09	Common Stock (40000)	Direct

Footnotes

F1: Reporting Person's right to receive Stock Options vest over a five year period, with the first 20% of the total Stock Options vesting on the one year anniversary of the grant date and the remainder of the shares will vest in equal installments on a annual basis thereafter, such that the Stock Options are fully vested on January 9, 2020.